Related Experiment Video
Updated: Mar 19, 2026

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
Insufficient access to oral paediatric medicines in Ghana: A descriptive study
Daniel N A Ankrah1,2, Joseph T Turkson3, Edith B Boateng4
1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. D.Ankrah@uu.nl.
Insights
This study found that many commonly prescribed pediatric medicines are unavailable in Ghana, requiring extemporaneous preparation. Some of these essential children's medicines lacked WHO approval or local registration, highlighting safety concerns.
Area of Science:
- Pharmacology
- Paediatric Medicine
- Public Health
Background:
- Children face significant healthcare access challenges, particularly concerning medication availability.
- Off-label prescription of pediatric medicines can lead to serious safety issues.
- This study focuses on frequently prescribed children's medicines that are not readily available in Ghana and are prepared extemporaneously.
Purpose of the Study:
- To identify frequently prescribed pediatric medicines that require extemporaneous preparation in Ghana.
- To assess the availability and regulatory status of these essential children's medicines.
- To highlight potential safety concerns associated with unlisted or unregistered pediatric medications.
Main Methods:
- Prescriptions for extemporaneous oral preparations for children at Korle-Bu Teaching Hospital were analyzed (November 2013 onwards).
- Data collected included medicine name, dosage, and prescribing facility.
- Medicines were cross-referenced with the World Health Organization Children's Medicine List and registered with the Food and Drugs Authority, Ghana.
Main Results:
- A total of 622 prescriptions for 35 different pediatric formulations were processed.
- Some prescribed medicines (e.g., Baclofen, Clonazepam) were not on the WHO Children's Medicine List or registered in Ghana.
- The majority of prescribed medicines (88.6%) were for non-communicable diseases.
Conclusions:
- Pediatric prescriptions, including off-label medications, are frequently prepared extemporaneously in Ghana.
- Urgent measures are needed to improve access to essential pediatric medicines.
- Enhanced monitoring of benefit-risk profiles for pediatric medicines is crucial for better treatment outcomes in children.
Background:
Among the most vulnerable people in society are children and this is especially so in their access to health care Off-label prescription of paediatric medicines is known to be associated with safety outcomes some of which may be serious. This study identifies frequently prescribed children's medicines that are not readily available in Ghana and are prepared extemporaneously.
Method:
All prescriptions for extemporaneous oral preparations for children presented to the local production unit of the Korle-Bu Teaching Hospital from November, 2013 were eligible for the study. Information from such prescriptions was recorded in a systematic format. Presence of the prescribed medicine on the World Health Organization Children's Medicine List was ascertained in addition to the anatomical and therapeutic classification code. The registration of the prescribed medicine for paediatric use by the Food and Drugs Authority, Ghana was also checked. Descriptive statistics of the data was presented.
Results:
In all 622 prescriptions for 35 different paediatric formulations were served. Prescriptions from several health facilities including government hospitals (6.6 %, N = 622), private hospitals (2.4 %, N = 622) and the University of Ghana hospital (1.1 %, N = 622) were all honoured. Some of the prescribed medicines (Baclofen, Clonazepam, Hydroxyurea and Lamotrigine) were neither on the World Health Organization Children's Medicine list nor registered with the Food and Drugs Authority, Ghana. Most prescribed medicines (88.6 %, N = 35) were for non-communicable diseases.
Conclusion:
Paediatric prescriptions including off-label medicines are prescribed and formulated extemporaneously in this setting. Steps should be taken to improve access and monitor benefit-risk profiles of paediatric medicines in order to improve treatment outcomes among children.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Inhaled Medications

